{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:55:35Z","timestamp":1789685735414,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.arbres.2019.08.023","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T18:34:07Z","timestamp":1574793247000},"page":"282-290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Caracter\u00edsticas cl\u00ednicas y riesgo de agudizaciones asociados con diferentes criterios diagn\u00f3sticos del solapamiento asma-EPOC"],"prefix":"10.1016","volume":"56","author":[{"given":"Juan Jos\u00e9","family":"Soler-Catalu\u00f1a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Novella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"S\u00e1nchez-Toril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Miravitlles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2019.08.023_bib0200","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-2600(17)30293-X","article-title":"Global, regional, and national deaths, prevalence, disability-adjusted life years, lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"5","author":"Soriano","year":"2017","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.arbres.2019.08.023_bib0205","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/02770903.2011.555576","article-title":"Overlap syndrome of asthma and COPD predicts low quality of life","volume":"48","author":"Kauppi","year":"2011","journal-title":"J Asthma."},{"key":"10.1016\/j.arbres.2019.08.023_bib0210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1378\/chest.15-1055","article-title":"Defining the asthma-COPD overlap syndrome in a COPD cohort","volume":"149","author":"Cosio","year":"2016","journal-title":"Chest."},{"key":"10.1016\/j.arbres.2019.08.023_bib0215","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S2213-2600(16)00098-9","article-title":"Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen city heart study: a prospective population-based analysis","volume":"4","author":"Lange","year":"2016","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.arbres.2019.08.023_bib0220","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1378\/chest.13-0622","article-title":"Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma","volume":"145","author":"Menezes","year":"2014","journal-title":"Chest."},{"key":"10.1016\/j.arbres.2019.08.023_bib0225","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1164\/rccm.201408-1458OC","article-title":"Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease","volume":"191","author":"Christenson","year":"2015","journal-title":"Am J Respir Crit Care."},{"key":"10.1016\/j.arbres.2019.08.023_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2015.10.004","article-title":"Understanding asthma-chronic obstructive pulmonary disease overlap syndrome","volume":"110","author":"Wurst","year":"2016","journal-title":"Respir Med."},{"key":"10.1016\/j.arbres.2019.08.023_bib0235","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.rmed.2013.03.007","article-title":"Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status","volume":"107","author":"Miravitlles","year":"2013","journal-title":"Respir Med."},{"key":"10.1016\/j.arbres.2019.08.023_bib0240","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1164\/rccm.201602-0353OC","article-title":"Asthma-like features and clinical course of\u00a0COPD: An analysis from the Hokkaido\u00a0COPD\u00a0Cohort Study","volume":"194","author":"Suzuki","year":"2016","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.arbres.2019.08.023_bib0245","doi-asserted-by":"crossref","first-page":"e62985","DOI":"10.1371\/journal.pone.0062985","article-title":"The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population","volume":"10","author":"De Marco","year":"2013","journal-title":"PloS One."},{"key":"10.1016\/j.arbres.2019.08.023_bib0250","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.arbres.2011.12.009","article-title":"Documento de consenso sobre el fenotipo mixto EPOC-asma en la EPOC","volume":"48","author":"Soler-Catalu\u00f1a","year":"2012","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2019.08.023_bib0255","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1183\/13993003.00436-2016","article-title":"What is asthma\u2212COPD overlap syndrome? Towards a consensus definition from a round table discussion","volume":"48","author":"Sin","year":"2016","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2019.08.023_bib0260","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.arbres.2017.04.002","article-title":"Consenso sobre el solapamiento de asma y EPOC (ACO) entre la Gu\u00eda Espa\u00f1ola de la EPOC (GesEPOC) y la Gu\u00eda Espa\u00f1ola para el Manejo del Asma (GEMA)","volume":"53","author":"Plaza","year":"2017","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2019.08.023_bib0265","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2213-2600(15)00106-X","article-title":"Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials","volume":"3","author":"Pascoe","year":"2015","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.arbres.2019.08.023_bib0270","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1164\/rccm.201502-0235LE","article-title":"Blood eosinophils: a biomarker of response to extrafine beclomethasone\/formoterol in chronic obstructive pulmonary disease","volume":"192","author":"Siddiqui","year":"2015","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.arbres.2019.08.023_bib0275","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa1713901","article-title":"Once-daily sijngle-inhaler triple versus dual therapy in patients with COPD","volume":"378","author":"Lipson","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arbres.2019.08.023_bib0280","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2213-2600(18)30006-7","article-title":"Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials","volume":"6","author":"Bafadhel","year":"2018","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.arbres.2019.08.023_bib0285","unstructured":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2019 Report [consultado 15 Ene 2019]. Disponible en: www.goldcopd.org"},{"issue":"Suppl. 1","key":"10.1016\/j.arbres.2019.08.023_bib0290","first-page":"2","article-title":"GEMA4.0. Gu\u00eda espa\u00f1ola para el manejo del asma","volume":"51","year":"2015","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2019.08.023_bib0295","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.arbres.2017.03.018","article-title":"Gu\u00eda espa\u00f1ola de la enfermedad pulmonar obtructiva cr\u00f3nica (GesEPOC) 2017. Tratamiento farmacol\u00f3gico en fase estable","volume":"53","author":"Miravitlles","year":"2017","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2019.08.023_bib0300","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.arbres.2013.04.001","article-title":"Spirometry. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR)","volume":"49","author":"Garc\u00eda-R\u00edo","year":"2013","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2019.08.023_bib0305","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1183\/09031936.00102509","article-title":"Development and first validation of the COPD Assessment Test","volume":"34","author":"Jones","year":"2009","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2019.08.023_bib0310","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaci.2003.09.008","article-title":"Development of the asthma control test: a survey for assessing asthma control","volume":"113","author":"Nathan","year":"2004","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.arbres.2019.08.023_bib0315","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/thx.54.7.581","article-title":"Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease","volume":"54","author":"Bestall","year":"1999","journal-title":"Thorax."},{"key":"10.1016\/j.arbres.2019.08.023_bib0320","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.2147\/COPD.S137872","article-title":"Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidlines: the FENEPOC study","volume":"12","author":"Calle","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"10.1016\/j.arbres.2019.08.023_bib0325","doi-asserted-by":"crossref","first-page":"e12049","DOI":"10.1097\/MD.0000000000012049","article-title":"Differences in prevalence of asthma-COPD overlap according to different criteria","volume":"97","author":"Song","year":"2018","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.arbres.2019.08.023_bib0330","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.arbres.2017.10.007","article-title":"Accuracy of a new algorithm to identify Asthma-COPD Overlap (ACO) patients in a cohort of patients with chronic obstructive airway disease","volume":"54","author":"Perez de Llano","year":"2018","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2019.08.023_bib0335","doi-asserted-by":"crossref","first-page":"e0210915","DOI":"10.1371\/journal.pone.0210915","article-title":"ACO: Time to move from the description of different phenotypes to the treatable traits","volume":"14","author":"Toledo-Pons","year":"2019","journal-title":"PloS One."},{"key":"10.1016\/j.arbres.2019.08.023_bib0340","doi-asserted-by":"crossref","first-page":"1602397","DOI":"10.1183\/13993003.02397-2016","article-title":"Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome?","volume":"49","author":"Cosio","year":"2017","journal-title":"Eur Respir."},{"key":"10.1016\/j.arbres.2019.08.023_bib0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-017-0667-x","article-title":"Asthma-COPD overlap is not a homogeneous disorder: Further supporting data","volume":"18","author":"P\u00e9rez-de-Llano","year":"2017","journal-title":"Respir Res."},{"key":"10.1016\/j.arbres.2019.08.023_bib0350","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.2147\/COPD.S129321","article-title":"Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD","volume":"12","author":"Song","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"10.1016\/j.arbres.2019.08.023_bib0355","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1183\/13993003.01659-2015","article-title":"Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD","volume":"47","author":"Schleich","year":"2016","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2019.08.023_bib0360","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1183\/13993003.01370-2015","article-title":"Blood eosinophils as a marker of response to inhaled corticosteroids in COPD","volume":"37","author":"Barnes","year":"2016","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2019.08.023_bib0365","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1164\/rccm.201509-1869OC","article-title":"Blood eosinophils and exacerbations in COPD: the Copenhagen General Population Study","volume":"193","author":"Vedel-Krogh","year":"2016","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.arbres.2019.08.023_bib0370","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/thoraxjnl-2015-207021","article-title":"Blood eosinophils and inhaled corticosteroid\/long-acting beta-2 agonist efficacy in COPD","volume":"71","author":"Pavord","year":"2016","journal-title":"Thorax."},{"key":"10.1016\/j.arbres.2019.08.023_bib0375","doi-asserted-by":"crossref","first-page":"1701162","DOI":"10.1183\/13993003.01162-2017","article-title":"Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD","volume":"50","author":"Casanova","year":"2017","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2019.08.023_bib0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15412555.2019.1575802","article-title":"Practical guide to the identification and diagnosis of asthma-COPD overlap (ACO)","volume":"16","author":"Nu\u00f1ez","year":"2019","journal-title":"COPD."},{"key":"10.1016\/j.arbres.2019.08.023_bib0385","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1164\/rccm.201108-1553OC","article-title":"Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease","volume":"186","author":"Bafadhel","year":"2012","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.arbres.2019.08.023_bib0390","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0140-6736(18)30206-X","article-title":"Extrafine inhaled therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial","volume":"391","author":"Papi","year":"2018","journal-title":"Lancet."}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289619303928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289619303928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:38:12Z","timestamp":1759531092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289619303928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0300289619303928"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2019.08.023","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Caracter\u00edsticas cl\u00ednicas y riesgo de agudizaciones asociados con diferentes criterios diagn\u00f3sticos del solapamiento asma-EPOC","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2019.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of SEPAR.","name":"copyright","label":"Copyright"}]}}